http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104983726-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08 |
| filingDate | 2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104983726-B |
| titleOfInvention | Tetrahydro xanthone dimer class compound is preparing the application in α 1-AR adrenoceptor antagonists drug |
| abstract | The present invention relates to the new application fields of known compound, specifically disclose tetrahydro xanthone dimer class compound in preparation α 1 Application in-AR adrenoceptor antagonists drug.The present invention has found tetrahydro xanthone dimer class compounds on adrenal receptor alpha by research for the first time 1 Three kinds of hypotype (α of-AR 1A , α 1B And α 1D ) there is antagonism, wherein tetrahydro xanthone dimer class compound dicerandrol B is to adrenoreceptor α 1B - AR has selective antagonism, can be used for preparing blood pressure lowering or treats the drug of benign prostatic hyperplasis. |
| priorityDate | 2015-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.